Novo Nordisk A/S
As a Senior Global Market Access Lead within Novo Nordisk's Diabetes and Access portfolio, you will own asset-level market access and payer value strategy across the entire product lifecycle. This role involves integrating payer insights and health technology assessment (HTA) strategies to drive reimbursement reality and therapy access in 194 countries. You will collaborate with cross-functional teams to develop business cases, shape submission plans, and mentor colleagues on strategic access initiatives.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
13% below the average for this role
Senior Director, Global Market Access, Diabetes Portfolio, Novo Nordisk
State of Indiana
Market Access Manager- Gulf Region
Abbott Laboratories
Senior Manager, Payer Evidence, Methods, & Access Affairs
AstraZeneca
TA Access Strategy & HEOR Head
Novartis
Value & Access Analyst
Novartis
Cluster V&A Director
Kyowa Kirin International plc